bioRxivBiophysicsPreprint
Boltz-Perturb: Improving Diversity and Accuracy in Protein-Ligand Co-Folding through Training-Free Conditioning Perturbation
Abstract
Protein-ligand co-folding models hold promise in structure-based drug discovery and small molecule interaction prediction, but often fail in predicting correct small molecule binding poses. We present Boltz-Perturb, a framework for addressing this through perturbing model conditioning signals during model inference, and show that such perturbations improve correct ligand binding mode predictions. We first show with true-coordinate injection experiments that the models learned energy landscape contains correct binding-mode basins, allowing us to reframe the problem as one of sampling deficiency. We then introduce two inference-time perturbation strategies, Token Bias Perturbation (TBP) and Token Conditioning Perturbation (TCP), which increase exploration of alternative binding poses. Across diverse protein-ligand systems, TCP improves top-20 oracle success rates by 2.6 to 7.8 fold. Boltz-Perturb attains higher oracle success rates compared to the Boltz-2 high diffusion temperature variant while requiring over 75% less compute. To our knowledge, this is the first systematic perturbation analysis of a co-folding architecture for small-molecule binding mode diversity. We demonstrate that inference-time perturbations can unlock latent structural diversity in generative co-folding models and improve protein-ligand predictions without costly retraining.
- assay: protein structure
- research focus: drug response / drug discovery
- approach: deep learning
- approach: diffusion model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeted finetuning enables co-folding models to learn ligand-induced protein conformational states
Rohan Gorantla, Christian Schleberger, Fabian Sesterhenn·bioRxiv·Sep 27, 2026
- Towards Generalizable Protein-ligand Co-folding with ACER
Nopsinth Vithayapalert, Francesca Grisoni·bioRxiv·Oct 1, 2026
- Comparative Assessment of the Utility of Co-Folding and Docking for Small-Molecule Drug Design
Ute F. Röhrig, Marine Bugnon, Vincent Zoete·bioRxiv·Apr 20, 2026
- Have protein-ligand co-folding methods moved beyond memorisation?
Peter Škrinjar, Jérôme Eberhardt, … Janani Durairaj·Nature Structural & Molecular BiologyPeer-reviewed·May 1, 2026
- Affinity Fine-Tuning of Boltz-2: An Open Framework for Protein-Ligand Potency Prediction in Drug Discovery
Samad Amini, Simone Sciabola, Ye Wang·bioRxiv·May 27, 2026
- Bento: Benchmarking Classical and AI Docking on Drug Design-Relevant Data
Marina A. Pak, Daria Frolova, … Dmitry N. Ivankov·bioRxiv·Dec 30, 2025